VD

Vijayan David

Active Director Director DIN 10357287
DIN 10357287 First appointment Oct 2023 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since Oct 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Vijayan David

Data last updated:

Vijayan David is a Director at Exapilog Private Limited (since 2023) and Designated Partner at Pharengen Cons Llp (since 2023). The companies operate in Pharma and Business Services.

DIN 10357287
Primary Designation Director
Industry Pharma
First Appointment 16 Oct 2023
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Exapilog Private Limited U46497TS2023PTC179819
Director08 Dec 20232023Active
Designated Partner16 Oct 20232023Active

Board colleagues of Vijayan David

NameDINCompanyDesignation
Raja Subburayalu10357288Exapilog Private Limited , Pharengen Cons LlpDirector

Directorship timeline

Open interactive timeline →
Exapilog Private Limited
Pharengen Cons Llp
Premium access

Shareholding and investment profile for Vijayan David

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vijayan David

Vijayan David currently holds 2 directorships: Exapilog Private Limited (Director, since 08 Dec 2023); Pharengen Cons Llp (Designated Partner, since 16 Oct 2023).

Vijayan David was first appointed on 16 Oct 2023 as Designated Partner at Pharengen Cons Llp.

The current boards of Vijayan David's companies include Raja Subburayalu (Exapilog Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available